Get the Stockscreener App
1.51
1.95%
-0.03
Lava Therapeutics Nv stock is traded at $1.51, with a volume of 637.63K.
It is down -1.95% in the last 24 hours and down -0.66% over the past month.
LAVA Therapeutics NV isa clinical stage immuno-oncology company. It is focused on transforming cancer treatment by developing a platform to selectively induce bispecific antibody utilizing the Gammabody platform for an undisclosed tumor associated antigen for the treatment of cancer. Company's pipeline include's products such as LAVA-1266, LAVA-1427, LAVA-1433, LAVA-1207, PF08046052, JNJ89853413.
See More
Previous Close:
$1.54
Open:
$1.53
24h Volume:
637.63K
Relative Volume:
6.43
Market Cap:
$39.72M
Revenue:
$9.06M
Net Income/Loss:
$-50.39M
P/E Ratio:
-0.7865
EPS:
-1.92
Net Cash Flow:
$5.89M
1W Performance:
-3.82%
1M Performance:
-0.66%
6M Performance:
+16.15%
1Y Performance:
-12.00%
1-Day Range:
$1.50
$1.5645
1-Week Range:
$1.50
$1.58
52-Week Range:
$0.8502
$2.093
Lava Therapeutics Nv Stock (LVTX) Company Profile
Name
Lava Therapeutics Nv
Sector
Industry
Phone
31 6 3000 3035
Address
YALELAAN 62, UTRECHT
Compare LVTX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
LVTX
Lava Therapeutics Nv
|
1.51 | 40.51M | 9.06M | -50.39M | 5.89M | -1.92 |
|
VRTX
Vertex Pharmaceuticals Inc
|
391.36 | 100.82B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
461.24 | 60.45B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
575.06 | 60.69B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
752.32 | 46.32B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
327.20 | 36.58B | 3.81B | -644.79M | -669.77M | -6.24 |
Lava Therapeutics Nv Stock (LVTX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-12-24 | Downgrade | Leerink Partners | Outperform → Market Perform |
| Dec-11-24 | Downgrade | JMP Securities | Mkt Outperform → Mkt Perform |
| Oct-25-22 | Initiated | H.C. Wainwright | Buy |
| Apr-19-21 | Initiated | JP Morgan | Overweight |
| Apr-19-21 | Initiated | Jefferies | Buy |
| Apr-19-21 | Initiated | SVB Leerink | Outperform |
View All
Lava Therapeutics Nv Stock (LVTX) Latest News
Using R and stats models for LAVA Therapeutics N.V. forecastingSwing Trade & Community Consensus Picks - newser.com
Short interest data insights for LAVA Therapeutics N.V.July 2025 Technicals & Fast Momentum Stock Entry Tips - newser.com
Is LAVA Therapeutics NV benefiting from innovation trendsPortfolio Update Report & Technical Pattern Based Signals - خودرو بانک
How does LAVA Therapeutics N.V. compare to its peersMarket Growth Summary & High Conviction Trade Alerts - خودرو بانک
Can machine learning forecast LAVA Therapeutics N.V. recoveryRecession Risk & Daily Growth Stock Investment Tips - newser.com
Is LAVA Therapeutics N.V. stock bottoming out2025 Short Interest & Daily Profit Focused Screening - newser.com
Price Action: Is LAVA Therapeutics N.V. a stock for growth or value investors2025 Growth vs Value & Fast Entry and Exit Trade Plans - خودرو بانک
Is LAVA Therapeutics NV a stock for growth or value investorsJuly 2025 Final Week & Weekly Stock Breakout Alerts - خودرو بانک
Published on: 2025-09-15 20:23:03 - newser.com
Aug EndMonth: Is IVRPRC stock influenced by commodity pricesWeekly Market Summary & Daily Profit Maximizing Tips - خودرو بانک
Fed Meeting: How does LAVA Therapeutics N.V. compare to its peersStock Surge & Accurate Intraday Trade Tips - خودرو بانک
Published on: 2025-09-15 23:53:37 - خودرو بانک
Earnings Beat: Is LAVA Therapeutics NV a good ESG investmentGlobal Markets & Consistent Income Trade Recommendations - خودرو بانک
Aug Highlights: What is the Moat Score of LAVA Therapeutics NVQuarterly Trade Review & Low Drawdown Investment Ideas - خودرو بانک
Analyzing recovery setups for LAVA Therapeutics N.V. investorsWeekly Volume Report & Free AI Powered Buy and Sell Recommendations - newser.com
Aug Outlook: Is LAVA Therapeutics N.V. in a long term uptrend2025 Price Action Summary & Long-Term Capital Growth Ideas - خودرو بانک
Applying big data sentiment scoring on LAVA Therapeutics N.V.2025 Market Trends & Detailed Earnings Play Strategies - newser.com
Is LAVA Therapeutics N.V. forming a reversal pattern2025 Sector Review & Fast Exit Strategy with Risk Control - newser.com
Using portfolio simulators with LAVA Therapeutics N.V. includedJuly 2025 Sentiment & Risk Controlled Stock Pick Alerts - newser.com
LAVA Therapeutics N.V. stock outlook for YEARJuly 2025 Closing Moves & Scalable Portfolio Growth Ideas - newser.com
Is LAVA Therapeutics N.V. stock reversal real or fakeJuly 2025 Momentum & Low Risk High Reward Trade Ideas - newser.com
Should you wait for a breakout in LAVA Therapeutics N.V.Buy Signal & Free Community Supported Trade Ideas - Newser
Combining machine learning predictions for LAVA Therapeutics N.V.July 2025 Catalysts & High Accuracy Swing Trade Signals - Newser
Real time alert setup for LAVA Therapeutics N.V. performanceMarket Movers & Low Drawdown Momentum Ideas - Newser
Is LAVA Therapeutics N.V. a candidate for recovery play2025 Price Targets & Low Drawdown Investment Strategies - Newser
Strategies to average down on LAVA Therapeutics N.V.Quarterly Growth Report & Verified Short-Term Trading Plans - Newser
Is LAVA Therapeutics N.V. stock entering bullish territory2025 Short Interest & Community Trade Idea Sharing - Newser
Will LAVA Therapeutics N.V. benefit from macro trendsMarket Trend Summary & Smart Allocation Stock Tips - Newser
Using data tools to time your LAVA Therapeutics N.V. exitJuly 2025 Short Interest & Safe Capital Growth Stock Tips - Newser
Will LAVA Therapeutics N.V. bounce back from current supportPortfolio Return Summary & Low Drawdown Momentum Ideas - Newser
Chart based analysis of LAVA Therapeutics N.V. trends2025 Volatility Report & Low Drawdown Trading Techniques - Newser
Detecting price anomalies in LAVA Therapeutics N.V. with AIAnalyst Downgrade & Fast Entry and Exit Trade Plans - Newser
Leading vs lagging indicators on LAVA Therapeutics N.V. performanceJuly 2025 Analyst Calls & AI Enhanced Trading Signals - Newser
Building trade automation scripts for LAVA Therapeutics N.V.Forecast Cut & AI Based Buy and Sell Signals - Newser
Earnings visualization tools for LAVA Therapeutics N.V.2025 Retail Activity & Real-Time Stock Entry Alerts - Newser
How moving averages guide LAVA Therapeutics N.V. tradingEarnings Growth Report & Low Drawdown Investment Ideas - Newser
LAVA Therapeutics N.V. stock trendline breakdownTrade Analysis Summary & Technical Confirmation Trade Alerts - Newser
Lava Therapeutics Nv Stock (LVTX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.77%
1.53%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):